JP2026016486A5 - - Google Patents

Info

Publication number
JP2026016486A5
JP2026016486A5 JP2025175228A JP2025175228A JP2026016486A5 JP 2026016486 A5 JP2026016486 A5 JP 2026016486A5 JP 2025175228 A JP2025175228 A JP 2025175228A JP 2025175228 A JP2025175228 A JP 2025175228A JP 2026016486 A5 JP2026016486 A5 JP 2026016486A5
Authority
JP
Japan
Prior art keywords
cyclodextrin
free
pharmaceutical composition
chlorobutanol
dmso
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025175228A
Other languages
English (en)
Japanese (ja)
Other versions
JP2026016486A (ja
Filing date
Publication date
Priority claimed from PCT/US2021/012826 external-priority patent/WO2021142360A1/en
Application filed filed Critical
Publication of JP2026016486A publication Critical patent/JP2026016486A/ja
Publication of JP2026016486A5 publication Critical patent/JP2026016486A5/ja
Pending legal-status Critical Current

Links

JP2025175228A 2020-01-10 2025-10-17 安定なシクロデキストリン不含カルフィルゾミブ処方物 Pending JP2026016486A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202062959829P 2020-01-10 2020-01-10
US62/959,829 2020-01-10
PCT/US2021/012826 WO2021142360A1 (en) 2020-01-10 2021-01-08 Stable cyclodextrin free carfilzomib formulation
JP2022541814A JP2023510258A (ja) 2020-01-10 2021-01-08 安定なシクロデキストリン不含カルフィルゾミブ処方物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022541814A Division JP2023510258A (ja) 2020-01-10 2021-01-08 安定なシクロデキストリン不含カルフィルゾミブ処方物

Publications (2)

Publication Number Publication Date
JP2026016486A JP2026016486A (ja) 2026-02-03
JP2026016486A5 true JP2026016486A5 (https=) 2026-04-01

Family

ID=74626106

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022541814A Pending JP2023510258A (ja) 2020-01-10 2021-01-08 安定なシクロデキストリン不含カルフィルゾミブ処方物
JP2025175228A Pending JP2026016486A (ja) 2020-01-10 2025-10-17 安定なシクロデキストリン不含カルフィルゾミブ処方物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022541814A Pending JP2023510258A (ja) 2020-01-10 2021-01-08 安定なシクロデキストリン不含カルフィルゾミブ処方物

Country Status (5)

Country Link
US (1) US20250345384A1 (https=)
EP (1) EP4087538A1 (https=)
JP (2) JP2023510258A (https=)
CN (1) CN115279339A (https=)
WO (1) WO2021142360A1 (https=)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340736A (en) 1991-05-13 1994-08-23 The President & Fellows Of Harvard College ATP-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting
AU4499697A (en) 1996-09-13 1998-04-02 New York University Method for treating parasitic diseases with proteasome inhibitors
TWI674262B (zh) * 2011-01-10 2019-10-11 美商英菲尼提製藥股份有限公司 製備異喹啉酮之方法及異喹啉酮之固體形式
PH12012502259A1 (en) * 2012-05-08 2019-07-03 Onyx Therapeutics Inc Cylodextrin complexation methods for formulating peptide proteasome inhibitors
EP2914296B2 (en) * 2012-11-01 2021-09-29 Infinity Pharmaceuticals, Inc. Treatment of cancers using pi3 kinase isoform modulators
PT2865391T (pt) * 2013-10-22 2017-12-22 Medac Ges Für Klinische Spezialpräparate Mbh Processo para a produção de uma composição farmacêutica liofilizada com um conteúdo de mitomicina c
WO2015198257A1 (en) * 2014-06-26 2015-12-30 Intas Pharmaceuticals Ltd. Stable carfilzomib injection
CA2966288A1 (en) * 2014-10-30 2016-05-06 Big Dna Ltd Combination therapy
WO2016116882A2 (en) * 2015-01-23 2016-07-28 Leiutis Pharmaceuticals Pvt Ltd Novel compositions of carfilzomib
TWI759301B (zh) * 2016-05-24 2022-04-01 美商安美基公司 聚乙二醇化卡非佐米化合物

Similar Documents

Publication Publication Date Title
JP5936546B2 (ja) 6−フルオロ−3−ヒドロキシ−2−ピラジンカルボキサミドのメグルミン塩
CN102264351B (zh) 包含水溶性差的药物的聚合胶束组合物的制备方法
TW201219375A (en) Sodium salt of 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
JP6461945B2 (ja) ある含有量のマイトマイシンcを有する凍結乾燥医薬組成物を製造する方法
CN110876259B (zh) 注射用组合物
JP2002503704A (ja) ジデムニン(Didemnin)化合物の医薬製剤
WO2016059590A1 (en) Stable injectable composition of small molecule drugs and process for its preparation
JP2021520400A (ja) エダラボン医薬組成物
JP4142149B2 (ja) バンコマイシンの凍結乾燥製剤
CN102512404A (zh) 一种姜黄素类化合物肺靶向制剂及其制备方法与应用
JP2023116657A (ja) 安定な滅菌性且つ結晶性o-アセチルサリチル酸(アスピリン)のバイアル内堆積物
WO2017013591A1 (en) Stabilized liquid formulation of levothyroxine
HUP0500842A2 (hu) Dronedaront tartalmazó gyógyászati készítmény parenterális adagolásra
JPWO2008081829A1 (ja) 難水溶性薬物の溶解性維持用アミノアルキルメタアクリレートコポリマーe
KR101468153B1 (ko) 5α-안드로스테인-3β,5,6β-트리올 주사제 및 제조방법
JP5070670B2 (ja) N−[o−(p−ピバロイルオキシベンゼンスルホニルアミノ)ベンゾイル]グリシン・モノナトリウム塩・4水和物の凍結乾燥製剤およびその製造方法
JP6165986B2 (ja) ボルテゾミブを含む医薬組成物
JP2026016486A5 (https=)
WO2012013117A1 (zh) 含维生素c或其衍生物的替莫唑胺药物组合物及其制备方法
JPWO2002007724A1 (ja) N−[o−(p−ピバロイルオキシベンゼンスルホニルアミノ)ベンゾイル]グリシン・モノナトリウム塩・4水和物の凍結乾燥製剤およびその製造方法
JP7271517B2 (ja) シポニモドを含む非経口製剤
CN101378759A (zh) 三唑并嘧啶化合物的冻干组合物
CN102058548A (zh) 一种供注射用的盐酸氨溴索组合物及其制备方法
TW202432120A (zh) 注射用組合物、包含其之醫藥調配物以及製備該組合物之方法
KR102413426B1 (ko) 나라트립탄을 포함하는 구강용해 필름 제형